One of the most aggressive cancers, often diagnosed late. Risk factors: smoking, diabetes, chronic pancreatitis, obesity, family history. Early detection is critical; nutrition supports both prevention and treatment tolerance.
Last updated:
Pancreatic cancer is among the most aggressive malignancies, with a current overall 5-year survival rate of ~13%. The dominant form (~85-90%) is pancreatic ductal adenocarcinoma (PDAC), arising from cells lining pancreatic ducts. Less common types include neuroendocrine tumors (PNETs) which have dramatically better prognosis.
The pancreas sits deep in the abdomen, allowing tumors to grow undetected. By the time symptoms emerge (jaundice, weight loss, abdominal pain), most cancers have already spread locally or distantly. Only ~20% are resectable at diagnosis, and resection is the only path to potential cure.
Risk factors include smoking, obesity, diabetes (both cause and consequence), chronic pancreatitis, family history (BRCA1/2, PALB2, ATM, Lynch syndrome, 5-10% are hereditary), and aging. New-onset diabetes after age 50 may be the earliest sign, pancreatic cancer can cause diabetes 1-3 years before diagnosis.
Confined to pancreas without vascular involvement. Whipple procedure or distal pancreatectomy. 5-year survival ~30%. Adjuvant chemotherapy essential.
Spread to liver, lungs, peritoneum. Systemic chemo (FOLFIRINOX or gemcitabine + nab-paclitaxel). Median survival improving but typically 1-2 years. Palliative care critical.
Often vague and easily missed until advanced. Combination of symptoms in middle-aged or older adults warrants evaluation. New-onset diabetes is increasingly recognized as a critical early sign.
Yellow eyes/skin, dark urine, pale stools, itching. Tumor at pancreatic head obstructs common bile duct. Often THE presenting feature in resectable disease. URGENT evaluation.
Significant unintentional weight loss (10+ pounds). Often accompanied by reduced appetite, early satiety, taste changes.
Increasingly recognized: new diabetes after 50, especially with weight loss, may precede pancreatic cancer diagnosis by 1-3 years. ENDPAC score helps identify high-risk patients for imaging.
Persistent dull ache in epigastric area radiating to back. Worse lying flat, better leaning forward. Often progressive. Indicates tumor invading retroperitoneal nerves.
Pale, greasy, foul-smelling, floating stools. Indicates pancreatic enzyme insufficiency from tumor blocking duct. Often accompanies weight loss.
Especially with tumor in head/body. May cause gastric outlet obstruction. Feeling full after small meals. Persistent nausea unexplained.
Pancreatic cancer is highly thrombogenic, Trousseau's syndrome. Unexplained DVT or PE, especially "migrating" clots, may be presenting feature.
New-onset depression is sometimes a paraneoplastic phenomenon preceding pancreatic cancer diagnosis. Combined with weight loss, raises suspicion.
Multiphasic CT with pancreatic protocol. Identifies tumor, assesses vascular involvement (defines resectability), detects metastases. First-line imaging.
Better for cystic lesions, liver metastases. MRCP visualizes pancreatic and biliary ducts. Adjunct to CT.
Endoscopic ultrasound with fine-needle aspiration. Most accurate biopsy method. Tissue for diagnosis + molecular testing.
For biliary stent placement to relieve obstructive jaundice + brush cytology. Therapeutic + diagnostic.
CRITICAL nutritional support during conventional treatment. Cachexia is leading cause of death in pancreatic cancer.
High calorie, high protein, with pancreatic enzymes at every meal. Cachexia prevention is paramount. Small frequent meals.
Eggs, fish, poultry, dairy, legumes. 1.2-1.5g/kg/day minimum. Take pancreatic enzymes with every protein-containing meal.
Eggs, fish, well-cooked vegetables, smoothies. Avoid very high-fiber foods if causing GI distress.
Olive oil, avocado, fatty fish. Need calorie-dense food + pancreatic enzymes to absorb. MCT oil bypasses pancreatic lipase needs.
5-6 small meals/day vs 3 large. Better tolerance, improved absorption with enzymes, prevents nausea.
Diarrhea common (from disease and chemo). Track intake. Electrolyte solutions if losing significant volume.
Doubles pancreatic cancer risk. Continuing to smoke after diagnosis worsens treatment response. Quit at any time helps.
Heavy use causes chronic pancreatitis โ cancer risk. During treatment, abstain, affects liver, drug metabolism, healing.
Cause diarrhea, steatorrhea, weight loss. Always take pancreatic enzymes (PERT) with fatty meals. MCT oil better tolerated.
Pro-inflammatory, low nutrient density. Spend caloric intake on nutrient-dense foods that fight cachexia.
During chemo-induced neutropenia: avoid raw sushi, raw eggs, unpasteurized dairy, raw sprouts. Infection risk.
CRITICAL: Pancreatic enzymes are the #1 supplement. Coordinate with oncology, many interactions with chemo.
| Supplement | Mechanism & Evidence | Suggested Dose | Timing | Notes |
|---|---|---|---|---|
| Pancreatic Enzymes (PERT) | ESSENTIAL, most patients deficient. Improves digestion, absorption, weight, energy, treatment tolerance. | 40,000-80,000 USP lipase per meal; 25,000 per snack | With every meal AND snack | Creon, Zenpep, Pancreaze, by prescription. Open capsule onto food if can't swallow. Doses often underestimated. |
| Fat-Soluble Vitamins (A, D, E, K) | Universal deficiency in pancreatic exocrine insufficiency. Test and replace. | Multivitamin + extra D 5,000 IU + K2 200mcg | With fat meal + PERT | Test D level. Measure A and E levels if symptomatic. |
| Omega-3 (EPA/DHA) | Anti-cachexia effects (Cochrane review). May improve weight maintenance during chemo. | 2,000-4,000mg EPA+DHA/day | With fat meal + PERT | Discuss with oncologist; some interactions with chemo. |
| Curcumin (Bioavailable) | Anti-inflammatory; small trials show benefit in pancreatic cancer adjunct. | 500-1,500mg/day (bioavailable form) | With fat meal | Discuss timing with oncologist. |
| Vitamin D3 | Universal deficiency. Possibly affects prognosis. Anti-cancer effects in lab. | 5,000+ IU/day (titrate to 50-80 ng/mL) | With fat meal + PERT | Higher doses often needed due to malabsorption. Test 3 months. |
| MCT Oil (Medium-Chain Triglycerides) | Absorbs without pancreatic lipase, calorie source that bypasses enzyme deficiency. | 1-3 tablespoons/day | Throughout day | Start low to avoid GI upset. Add to smoothies, coffee. |
| Whey Protein / Protein Powder | Easy way to boost protein intake when appetite limited. High-quality amino acid source. | 20-40g protein/day from supplement | Between meals or with meals | Choose pancreatic-friendly forms, whey isolate or hydrolyzed if maldigesting. |
| Glutamine | Reduces chemo-induced mucositis, neuropathy. Supports gut barrier. | 10-30g/day during chemo | Divided doses | Some controversy; discuss with oncologist. |
Pancreatic cancer requires multimodal care at a high-volume center. Pancreatic enzyme replacement at every meal, aggressive nutrition to prevent cachexia, smoking cessation, family genetic testing, and early palliative care integration all matter. Clinical trials are strongly encouraged, therapy is evolving rapidly.